Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM71E2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COX6B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT5C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM190 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM238 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6805 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM150B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2S - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRSK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSPBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP6R1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM86B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPRH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on